Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound.
about
Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular riskDebate: Are surrogate end-point studies worth the effort?Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitorsUtility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies.Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee.Increased carotid artery intimal-medial thickness: risk factor for exercise-induced myocardial ischemia in asymptomatic older individuals.A "hot" topic in dyslipidemia management--"how to beat a flush": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention.Haemodynamics, wall mechanics and atheroma: a clinician's perspective.Preclinical atherosclerosis covaries with individual differences in reactivity and functional connectivity of the amygdala.Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.Niacin dosing: relationship to benefits and adverse effects.The antiatherogenic effects of antihypertensive treatment: trials completed and ongoing.Assessment of subclinical atherosclerosis and cardiovascular risk.Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trialMeasurement of carotid intima-media thickness to assess progression and regression of atherosclerosis.Does nicotinic acid (niacin) lower blood pressure?Endothelial arginase II and atherosclerosis.A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families.Emerging, noninvasive surrogate markers of atherosclerosis.Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy.Extended-release niacin/lovastatin: the first combination product for dyslipidemia.Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis.Significance of the intima-media thickness of carotid and thoracic aorta in coronary artery disease in the South Indian populationClinical update on the use of niacin for the treatment of dyslipidemia.Carotid intima-medial thickness measured on multiple ultrasound frames: evaluation of a DICOM-based software system.Physical activity and stroke risk.Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucoseManagement of extracranial carotid artery diseaseThematic review series: patient-oriented research. Imaging atherosclerosis: state of the art.Imaging Atherosclerosis by Carotid Intima-media Thickness in vivo: How to, Where and in Whom ?Patients at high risk for ischemic stroke: identification and actions.Impact of ezetimibe on atherosclerosis: is the jury still out?Risk factor management to prevent first stroke.Form to function: current and future roles for atherosclerosis imaging in drug development.Niacin for stroke prevention: evidence and rationale.Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice.Determination of site-specific carotid-intima media thickness: common -carotid artery and carotid bifurcation in hypercholesterolemia patients.Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review.Carotid intima-media thickness: knowledge and application to everyday practice.
P2860
Q24626884-20A244B4-0691-47B5-8B47-01EF0A7A95F4Q24792553-6C5989BF-98C5-49A2-9975-9867ED8439B8Q24803555-7172DD35-4707-4F9F-B314-A3624AC9B85AQ30401532-B46690CA-7672-43A5-AB80-D7D9652FEBD7Q33572201-B91262BC-6BA0-4B4F-9FAE-95C56F070060Q33747447-AE6DEB56-9559-4D2E-938B-B96B31B1F60BQ33765072-6698ECD1-E822-4146-BA2B-B8DDF1E0FC98Q33784649-527EB16F-5F1F-4154-A513-6E25BA18A63DQ33785683-2981DC3D-535F-4EB2-8E85-16CD3C006C29Q33789084-C4F83141-9EAE-4712-8813-693051E50328Q33928599-A7FD0D25-67E5-445B-A5E2-C38255E222FCQ34317671-08E1C99A-3D9F-44E5-8981-9FB36B0C04F9Q34397021-8E35DF30-91AB-4015-93CA-970AE1C61328Q34482151-45DDADAC-C72F-4631-8392-EF54AE5B9C80Q34571157-D5AC00BF-C25B-46AA-AE62-19CE84F09544Q34760603-B1057AC9-935B-443E-8775-BCC6540C3EC2Q34894236-C24CBEB4-6A82-4DD1-AE12-3FD0E69C4C63Q35161493-634F64D9-53D0-4A58-88FD-0CC597678E33Q35448532-E89F6748-4DFE-46F0-8CC2-0B92CAD183E7Q35602787-912EA028-7C46-430F-9D57-7F7877CF309EQ35640331-D3EED06D-AE6F-4431-8D62-5CA902672C1FQ35821875-634BA33F-BF30-430B-A7D5-4C43C2359355Q35824614-4AA2EDAF-A1D5-47A4-A3F2-AB90F59197D4Q35936351-E276B9C4-1660-4E82-8B4A-F0818316B560Q36007094-FF7E4F23-8D8C-48F1-BFF5-E7890E957589Q36178056-3E054C72-6768-4B0A-B0D8-50650DCE3F4AQ36201749-7696A359-E34C-4B77-884B-5A8CE813951BQ36274187-F4F5DCE6-AC71-418B-9292-005A834D88FEQ36412642-26978114-6C32-4727-9751-F747781A628AQ36480698-0A004D4F-8D1E-4786-B971-2C12EFECAB5EQ36568872-57876F98-F825-41C1-AC9F-8AFD875DEB09Q36986373-26569493-CD42-4ED2-8DA5-B514F830BB94Q37151389-C65F6924-7057-46CC-9242-B6E5C2A3F742Q37153566-4E702B7D-5EE9-42A1-890C-A7E0D9A9F5BDQ37165155-552AE635-089F-4B6E-B999-E150FD717708Q37336888-B59D62D6-2077-4A35-A986-BF4AA8BBBBDFQ37367674-645082F8-A007-45AE-B3E6-4F242EFA177DQ37382727-B244C6B8-FAAE-471F-83BB-6B2E0050DE46Q37494202-F87A7DA7-725A-45CC-945B-DA23E24A50AAQ37682540-0666D153-7B4E-4F35-8C19-333ACC0B0CD8
P2860
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Beneficial effects of colestip ...... ckness measured by ultrasound.
@en
Beneficial effects of colestip ...... ckness measured by ultrasound.
@nl
type
label
Beneficial effects of colestip ...... ckness measured by ultrasound.
@en
Beneficial effects of colestip ...... ckness measured by ultrasound.
@nl
prefLabel
Beneficial effects of colestip ...... ckness measured by ultrasound.
@en
Beneficial effects of colestip ...... ckness measured by ultrasound.
@nl
P2093
P356
P1433
P1476
Beneficial effects of colestip ...... ckness measured by ultrasound.
@en
P2093
Alaupovic P
Blankenhorn DH
Crawford DW
P356
10.1161/01.CIR.88.1.20
P407
P577
1993-07-01T00:00:00Z